Illumina Deepens Commitment to Customers in China with New Manufacturing Site
August 30, 2022
Investment in new Shanghai-based facility will allow the company to better serve its customers and meet growing demand SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of its first manufacturing site in China. The new Shanghai-based facility enables localized production for Illumina's gene [...]
August 29, 2022
ROCKVILLE, MD – The American Society of Human Genetics (ASHG) today announced that the Illumina Corporate Foundation has awarded the Society a $175,000, one-year grant to support the ASHG Learning Center, a website portal that offers scientists from the genetics and genomics field access to professional education videos, webinars, workshops, and other content. Delivering year-round [...]
Doble Simplifies Long-term Accurate Dissolved Gas Monitoring with Calisto® R9
August 29, 2022
Next generation online monitor combines infrared gas measurements with automated on-board calibration using water vapor MARLBOROUGH, Mass. – Doble Engineering Company, a leader in power grid diagnostic solutions, today announced the release of the Calisto R9 Dissolved Gas Analysis (DGA) Monitor. Ground-breaking new technologies allow Calisto R9 to deliver accurate gas readings over the long haul [...]
Emerson Opens Gas Analysis Solutions Center to Help Plants Meet Sustainability Goals
August 29, 2022
New Scotland-based center will develop and provide training for next-generation gas sensing technologies used for emissions monitoring, process control and safety SHAKOPEE, Minn. – Today Emerson announced the opening of a facility in Cumbernauld, Scotland, equipped with engineering, development and manufacturing resources for sensor, mechanical, electronics and software design for the company’s gas analysis portfolio. Spurred [...]
ATL Announces Additional METRC Verification in Massachusetts
August 29, 2022
Accelerated Technology Laboratories, Inc. (ATL), a leader in Laboratory Information Management Systems (LIMS), is pleased to announce its METRC (Marijuana Enforcement Tracking Reporting Compliance) verification in Massachusetts. ATL has been METRC verified in California, Colorado, Nevada, and Oregon since 2018, and has future plans for additional states. With this addition, ATL’s LIMS solutions, Sample Master® [...]
August 29, 2022
Global conference to focus on advancing the life-saving impacts of genomic health care SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will feature International Tennis Hall of Fame member Chris Evert as a special guest at its inaugural Illumina Genomics Forum (IGF) on [...]
August 29, 2022
New nanoElute 2 features nano-LC advances, supports automated single cell sample preparation from label-free ProteoCHIP on CellenONE platform MetaboScape ® 2023 advances fluxomics applications and ion mobility offset mass aligned (‘MOMA’) events for high-throughput 4D-Metabolomics Advances in MALDI HiPLEX-IHC™ workflows, and in PaSER™ on-the-fly intelligent acquisition software for 4D-Metaproteomics MAASTRICHT, Netherlands -- At the International Mass Spectrometry [...]
August 29, 2022
New mass spectrometry instrument and consumables launch during IMSC 2022 MAASTRICHT, Netherlands -- IMSC 2022 – Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing a new mass spectrometry instrument and consumables that enable biopharmaceutical and proteomics customers to drive scientific breakthroughs and solve analytical challenges. The company will showcase these innovations during [...]
Olympus Agree on Transfer of Evident to Bain Capital
August 29, 2022
Evident to accelerate its growth and innovation Tokyo – Olympus Corporation (“Olympus”) and EVIDENT Co., Ltd. ("Evident"), a wholly-owned subsidiary of Olympus announced today that Olympus concluded a definitive agreement with Bain Capital Private Equity, LP (“Bain Capital”), regarding the transfer of Evident. Based on this agreement, all shares of Evident will be transferred to [...]
Gilde Healthcare Acquires Sanquin Reagents
August 29, 2022
Utrecht (the Netherlands) -- The specialized private equity fund invests in scaling-up production and development of new medical tests Gilde Healthcare, a specialized healthcare investor, today announces its intention to acquire Sanquin Reagents from Sanquin Health Solutions (SHS) with its private equity fund. Sanquin Reagents produces and sells blood group and immune reagents, materials needed [...]

